Mark Chilvers

4.7k total citations · 1 hit paper
65 papers, 2.4k citations indexed

About

Mark Chilvers is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Surgery. According to data from OpenAlex, Mark Chilvers has authored 65 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Pulmonary and Respiratory Medicine, 12 papers in Epidemiology and 9 papers in Surgery. Recurrent topics in Mark Chilvers's work include Cystic Fibrosis Research Advances (43 papers), Neonatal Respiratory Health Research (12 papers) and Tracheal and airway disorders (11 papers). Mark Chilvers is often cited by papers focused on Cystic Fibrosis Research Advances (43 papers), Neonatal Respiratory Health Research (12 papers) and Tracheal and airway disorders (11 papers). Mark Chilvers collaborates with scholars based in Canada, United Kingdom and United States. Mark Chilvers's co-authors include Connie Yang, Mark Montgomery, Sarah J Nevitt, C O’Callaghan, Jane C. Davies, Andrew Rutman, Claire Wainwright, Sally Rodriguez, À. Munck and Michelle S. Howenstine and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and PLoS ONE.

In The Last Decade

Mark Chilvers

61 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Efficacy and Safety of Ivacaftor in Patients Aged 6 to 11 Years with Cystic Fibrosis with a G551D Mutation

2013 369 citations Jane C. Davies, Claire Wainwright et al. American Journal of Respiratory and Critical Care Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Chilvers Canada	25	1.7k	347	316	241	176	65	2.4k
Malena Cohen‐Cymberknoh Israel	22	1.2k 0.7×	286 0.8×	188 0.6×	261 1.1×	145 0.8×	85	1.7k
Micha Aviram Israel	24	1.4k 0.8×	549 1.6×	240 0.8×	352 1.5×	298 1.7×	56	2.3k
Jennifer L. Taylor‐Cousar United States	31	2.8k 1.6×	432 1.2×	121 0.4×	372 1.5×	234 1.3×	126	3.3k
Henry L. Dorkin United States	26	1.5k 0.9×	461 1.3×	366 1.2×	320 1.3×	336 1.9×	42	2.5k
Jochen G. Mainz Germany	23	2.4k 1.4×	626 1.8×	173 0.5×	278 1.2×	299 1.7×	107	3.1k
Harriet Corvol France	34	2.0k 1.2×	721 2.1×	303 1.0×	419 1.7×	380 2.2×	148	3.1k
Jeremy Hull United Kingdom	23	1.1k 0.6×	370 1.1×	113 0.4×	444 1.8×	241 1.4×	40	2.1k
Hanne Vebert Olesen Denmark	24	1.5k 0.9×	347 1.0×	80 0.3×	336 1.4×	119 0.7×	73	2.2k
George M. Solomon United States	28	1.3k 0.8×	303 0.9×	81 0.3×	210 0.9×	168 1.0×	83	1.8k
Philippe Reix France	22	1.2k 0.7×	188 0.5×	73 0.2×	191 0.8×	243 1.4×	124	1.7k

Countries citing papers authored by Mark Chilvers

Since Specialization

Citations

This map shows the geographic impact of Mark Chilvers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Chilvers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Chilvers more than expected).

Fields of papers citing papers by Mark Chilvers

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Chilvers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Chilvers. The network helps show where Mark Chilvers may publish in the future.

Co-authorship network of co-authors of Mark Chilvers

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Chilvers. A scholar is included among the top collaborators of Mark Chilvers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Chilvers. Mark Chilvers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mall, Marcus, Claire Wainwright, Julian Legg, et al.. (2025). Elexacaftor/tezacaftor/ivacaftor in children aged ≥6 years with cystic fibrosis heterozygous for F508del and a minimal function mutation: results from a 96-week open-label extension study. European Respiratory Journal. 66(1). 2402435–2402435. 2 indexed citations

Blydt‐Hansen, Tom, et al.. (2022). Long‐term respiratory outcomes following solid organ transplantation in children: A retrospective cohort study. Pediatric Pulmonology. 57(9). 2244–2251.

Sawicki, Gregory S., Mark Chilvers, John McNamara, et al.. (2022). A Phase 3, open-label, 96-week trial to study the safety, tolerability, and efficacy of tezacaftor/ivacaftor in children ≥ 6 years of age homozygous for F508del or heterozygous for F508del and a residual function CFTR variant. Journal of Cystic Fibrosis. 21(4). 675–683. 10 indexed citations

Zlosnik, James E. A., Deborah A. Henry, Trevor J. Hird, et al.. (2020). Epidemiology of Burkholderia Infections in People with Cystic Fibrosis in Canada between 2000 and 2017. Annals of the American Thoracic Society. 17(12). 1549–1557. 11 indexed citations

Ooi, Chee Y., Carlo Castellani, Katherine Keenan, et al.. (2019). Immunoreactive trypsinogen levels in newborn screened infants with an inconclusive diagnosis of cystic fibrosis. BMC Pediatrics. 19(1). 369–369. 24 indexed citations

Layeghifard, Mehdi, Michelle Klingel, Sanja Stanojevic, et al.. (2018). Epidemiology of Clonal Pseudomonas Aeruginosa Infection in a Canadian Cystic Fibrosis Population. Annals of the American Thoracic Society. 15(7). 827–836. 12 indexed citations

Boikos, Constantina, Lawrence Joseph, David W. Scheifele, et al.. (2017). Adverse events following live-attenuated intranasal influenza vaccination of children with cystic fibrosis: Results from two influenza seasons. Vaccine. 35(37). 5019–5026. 1 indexed citations

Chilvers, Mark, et al.. (2016). Variation of Ciliary Beat Pattern in Three Different Beating Planes in Healthy Subjects. CHEST Journal. 151(5). 993–1001. 22 indexed citations

Yang, Connie, Mark Chilvers, Mark Montgomery, & Sarah J Nevitt. (2016). Dornase alfa for cystic fibrosis. Paediatric Respiratory Reviews. 21. 65–67. 45 indexed citations

10.

Ooi, Chee Y., Carlo Castellani, Katherine Keenan, et al.. (2015). Inconclusive Diagnosis of Cystic Fibrosis After Newborn Screening. PEDIATRICS. 135(6). e1377–e1385. 92 indexed citations

11.

Zlosnik, James E. A., Guohai Zhou, Rollin Brant, et al.. (2014). Burkholderia Species Infections in Patients with Cystic Fibrosis in British Columbia, Canada. 30 Years’ Experience. Annals of the American Thoracic Society. 12(1). 70–78. 74 indexed citations

12.

Yau, Yvonne, Félix Ratjen, Elizabeth Tullis, et al.. (2014). Randomized controlled trial of biofilm antimicrobial susceptibility testing in cystic fibrosis patients. Journal of Cystic Fibrosis. 14(2). 262–266. 42 indexed citations

13.

Davies, Jane C., Claire Wainwright, Gerard J. Canny, et al.. (2013). Efficacy and Safety of Ivacaftor in Patients Aged 6 to 11 Years with Cystic Fibrosis with a G551D Mutation. American Journal of Respiratory and Critical Care Medicine. 187(11). 1219–1225. 369 indexed citations breakdown →

14.

Sharma, Ashish, Roger Jen, Aaron F. Hirschfeld, et al.. (2012). Inflammasome-Mediated IL-1β Production in Humans with Cystic Fibrosis. PLoS ONE. 7(5). e37689–e37689. 56 indexed citations

15.

Davidson, A. George F., Mark Chilvers, & Yolanda Lillquist. (2012). Effects of a Pseudomonas aeruginosa eradication policy in a cystic fibrosis clinic. Current Opinion in Pulmonary Medicine. 18(6). 615–621. 10 indexed citations

16.

Prestidge, Chanel, et al.. (2010). Renal function in pediatric cystic fibrosis patients in the first decade of life. Pediatric Nephrology. 26(4). 605–612. 16 indexed citations

17.

Chilvers, Mark, et al.. (2009). Diagnostic Testing of Patients Suspected of Primary Ciliary Dyskinesia. American Journal of Respiratory and Critical Care Medicine. 181(4). 307–314. 91 indexed citations

18.

Chilvers, Mark. (2003). Functional analysis of cilia and ciliated epithelial ultrastructure in healthy children and young adults. Thorax. 58(4). 333–338. 102 indexed citations

19.

Chilvers, Mark, et al.. (2001). The effects of coronavirus on human nasal ciliated respiratory epithelium. European Respiratory Journal. 18(6). 965–970. 144 indexed citations

20.

Gomel, M, Brian Oldenburg, Judy M. Simpson, Mark Chilvers, & Neville Owen. (1997). Composite cardiovascular risk outcomes of a work-site intervention trial.. American Journal of Public Health. 87(4). 673–676. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact